Ningbo Menovo Pharmaceutical Co., Ltd.
public_traded
Ningbo Menovo Pharmaceutical Co., Ltd. is publicly traded on SHH under ticker 603538.SS.
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headquartered in Ningbo, China.